2009
DOI: 10.1586/erv.09.29
|View full text |Cite
|
Sign up to set email alerts
|

Strategies to overcome host immunity to adenovirus vectors in vaccine development

Abstract: The first clinical evaluations of adenovirus (Ad)-based vectors for gene therapy were initiated in the mid-1990s and led to great anticipation for future utility. However, excitement surrounding gene therapy, particularly Ad-based therapy, was diminished upon the death of Jesse Gelsinger, and recent discouraging results from the HIV vaccine STEP trial have brought efficacy and safety issues to the forefront again. Even so, Ad vectors are still considered among the safest and most effective vaccine vectors. Inn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
67
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 91 publications
(68 citation statements)
references
References 207 publications
1
67
0
Order By: Relevance
“…This initiated interest in the development of nonhuman AdVs, including FAdVs, which are an attractive choice both as vaccine vectors for poultry (15,16) and as gene therapy vectors. The optimization of delivery routes and application regimens of AdV vectors are also needed to counteract the limitations of HAdV-based vaccines (21). Moreover, oral administration of AdV vectors is better able to avoid systemic neutralizing antibodies than are other routes of administration (29,30).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This initiated interest in the development of nonhuman AdVs, including FAdVs, which are an attractive choice both as vaccine vectors for poultry (15,16) and as gene therapy vectors. The optimization of delivery routes and application regimens of AdV vectors are also needed to counteract the limitations of HAdV-based vaccines (21). Moreover, oral administration of AdV vectors is better able to avoid systemic neutralizing antibodies than are other routes of administration (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…All these studies suggest the importance of the left-end genes of the FAdV-9 genome in virus replication, immune response modulation, and vector design. Moreover, the optimization of delivery routes and regimens is important for overcoming the potential limitations of AdV-based vaccines for both human and animal applications (21).…”
mentioning
confidence: 99%
“…However, the use of viral vectors in medical applications presents some concerns because of their potential to alter the host genome by random integration of viral genes into the host genome (Fischer et al, 2011). Immunogenicity produced by viral proteins is another problem limiting the use of viral vectors (Thacker et al, 2009). Retroviral vectors do integrate into the host DNA to replicate and express the genes that they carry.…”
Section: Introductionmentioning
confidence: 99%
“…The adenovirus (Ad) expression system, one of the most widely-used viral expression systems, shows more advan-tages than other systems, such as easy construction, higher efficiency of gene transfer, higher titers and induction of humoral, mucosal and cellular immune responses (Benihoud et al, 1999;Douglas, 2007;Ferreira et al, 2005;Kovesdi et al, 1997;Thacker et al, 2009). Adenovirus vector system expressing PCV2 Cap protein has been studied, but has limited immune efficiency (Wang et al, 2006(Wang et al, , 2007.…”
Section: Introductionmentioning
confidence: 99%